EMA panel backs Amgen/AstraZeneca's asthma drug Tezspire; Ultomiris for expanded use

Retrieved on: 2022-07-22 13:46:13

Tags for this article:

Click the tags to see associated articles and topics

EMA panel backs Amgen/AstraZeneca's asthma drug Tezspire; Ultomiris for expanded use. View article details on hiswai:

Excerpt

A committee of the European Medicines Agency ((EMA)) recommended the approval of Amgen (AMGN) and AstraZeneca's (AZN) Tezspire as an add-on ...

Article found on: seekingalpha.com